Get started
Skye Bioscience, Inc.Skye Bioscience, Inc.Skye Bioscience, Inc.

Skye Bioscience, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

SKYE chart


Full chart

SKYE upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪44.29 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.73 USD
Net income (FY)
‪−26.57 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪17.94 M‬
Beta (1Y)
−0.29

Employees


Employees (FY)
16
Change (1Y)
+5 +45.45%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.66 M‬ USD

About Skye Bioscience, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Punit S. Dhillon
Website
skyebioscience.com
Headquarters
San Diego
Founded
2011
FIGI
BBG00433GZN1
Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new medicines that unlock the pharmaceutical potential of the endocannabinoid system to treat diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration. Its products include nimacimab and SBI-100 Ophthalmic Emulsion. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

SKYE news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as SKYE.

Frequently Asked Questions


The current price of SKYE is 1.23 USD — it has decreased by −2.10% in the past 24 hours. Watch Skye Bioscience, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Skye Bioscience, Inc. stocks are traded under the ticker SKYE.
SKYE stock has fallen by −38.86% compared to the previous week, the month change is a −44.00% fall, over the last year Skye Bioscience, Inc. has showed a −90.70% decrease.
We've gathered analysts' opinions on Skye Bioscience, Inc. future price: according to them, SKYE price has a max estimate of 21.00 USD and a min estimate of 14.00 USD. Watch SKYE chart and read a more detailed Skye Bioscience, Inc. stock forecast: see what analysts think of Skye Bioscience, Inc. and suggest that you do with its stocks.
SKYE reached its all-time high on Dec 12, 2014 with the price of 2,750.00 USD, and its all-time low was 1.44 USD and was reached on Nov 15, 2023. View more price dynamics on SKYE chart.
See other stocks reaching their highest and lowest prices.
SKYE stock is 14.74% volatile and has beta coefficient of −0.29. Track Skye Bioscience, Inc. stock price on the chart and check out the list of the most volatile stocks — is Skye Bioscience, Inc. there?
Today Skye Bioscience, Inc. has the market capitalization of ‪43.36 M‬, it has decreased by −5.78% over the last week.
Yes, you can track Skye Bioscience, Inc. financials in yearly and quarterly reports right on TradingView.
Skye Bioscience, Inc. is going to release the next earnings report on May 28, 2025. Keep track of upcoming events with our Earnings Calendar.
SKYE earnings for the last quarter are −0.24 USD per share, whereas the estimation was −0.28 USD resulting in a 13.80% surprise. The estimated earnings for the next quarter are −0.29 USD per share. See more details about Skye Bioscience, Inc. earnings.
Skye Bioscience, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
SKYE net income for the last quarter is ‪−9.75 M‬ USD, while the quarter before that showed ‪−3.90 M‬ USD of net income which accounts for −150.02% change. Track more Skye Bioscience, Inc. financial stats to get the full picture.
No, SKYE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 4, 2025, the company has 16 employees. See our rating of the largest employees — is Skye Bioscience, Inc. on this list?
Like other stocks, SKYE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Skye Bioscience, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Skye Bioscience, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Skye Bioscience, Inc. stock shows the sell signal. See more of Skye Bioscience, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.